QC Ware and IonQ Demonstrate High-Precision Hybrid Quantum Workflow for Drug Discovery
6 Articles
6 Articles
QC Ware and IonQ Demonstrate High-Precision Hybrid Quantum Workflow for Drug Discovery
/PRNewswire/ -- QC Ware today announced a technology demonstration of a hybrid quantum-classical chemistry workflow using its Promethium® platform and IonQ's...
IonQ, Inc. (IONQ) Stock: QC Ware Partnership Targets Quantum Drug Discovery
TLDR IonQ and QC Ware test hybrid quantum chemistry for faster drug discovery research IonQ Forte supports eight-qubit chemistry calculations through Amazon Braket cloud QC Ware reports interaction-energy results that meet chemical accuracy standards Promethium links GPU processing with IonQ Forte for advanced molecular modelling IonQ partnership expands trapped-ion quantum applications in pharmaceutical research IonQ [...] The post IonQ, Inc. (…
QC Ware and IonQ Achieve Chemical Accuracy in Hybrid Quantum Chemistry Workflow for Drug Discovery
Quantum software developer QC Ware and trapped-ion hardware vendor IonQ (NYSE: IONQ) have demonstrated a hybrid quantum-classical chemistry workflow combining QC Ware’s Promethium® platform with the IonQ Forte quantum computer. Executed via Amazon Braket and supported by AWS cloud compute credits, the joint test calculated electrostatic interaction energy within 0.5 kcal/mol (~4%) of classical benchmarks—clearing [...] The post QC Ware and IonQ …
QC Ware and IonQ Demonstrate High-Precision Hybrid Quantum Workflow for Drug Discovery - Business News Week
Joint test on IonQ Forte hardware lands within 4% of benchmark, clearing the chemical-accuracy bar for enzyme active-site modeling via Amazon Braket PALO ALTO, Calif., Sept. 1, 2026 /PRNewswire/ — QC Ware today announced a technology demonstration of a hybrid quantum-classical chemistry workflow using its Promethium® platform and IonQ’s Forte trapped-ion quantum computer via Amazon […] The post QC Ware and IonQ Demonstrate High-Precision Hybrid …
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium








